Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Inventory (2018 - 2019)

Aclaris Therapeutics has reported Inventory over the past 2 years, most recently at $189000.0 for Q3 2019.

  • Quarterly results put Inventory at $189000.0 for Q3 2019, down 81.9% from a year ago — trailing twelve months through Sep 2019 was $189000.0 (down 81.9% YoY), and the annual figure for FY2018 was $791000.0, changed.
  • Inventory for Q3 2019 was $189000.0 at Aclaris Therapeutics, up from $185000.0 in the prior quarter.
  • Over the last five years, Inventory for ACRS hit a ceiling of $1.0 million in Q3 2018 and a floor of $185000.0 in Q2 2019.